Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Spot On Sciences Launches Searchable Database of Dried Blood Spot Methods

Published: Friday, September 07, 2012
Last Updated: Friday, September 07, 2012
Bookmark and Share
Spot On Science’s free, publicly accessible database aids researchers by providing rapid access to published dried blood spot (DBS) test methods.

Spot On Sciences, Inc., an Austin-based medical device company, has just released a web-based searchable database that focuses exclusively on advances made in dried blood spot (DBS) methods and technology over the last 40 years. The database, the first and only one currently accessible to the public, is designed to help advance DBS adoption and assist bioscience researchers with work being done in diagnostic testing and medical research. Recent advances in DBS technology have elevated its value both as a sampling tool and vital component of laboratory analysis.

"Those of us in interested in DBS have been waiting for this type of research tool for a long time” said Dr. John Repass, former research scientist at M.D. Anderson Cancer Center and current Chief Scientist at ARQ Genetics. “This database allows an easier way for me to search and navigate through the myriad of studies scattered over hundreds of sources. It’s a great time-saver for anyone doing research and developing DBS methods.”

Spot On Sciences, Inc.’s CEO, Dr. Jeanette Hill, explained that “there’s been an explosion of methods and papers devoted to DBS and we detected the need within the bioscience community for this type of site-based resource. Anyone can come to our site and can browse by analyte or keywords to track down key information from over 1,000 entries.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Viable HIV Vaccine Confirmed by Study
HIV Study in macaques confirms clinically viable vaccine opening the way for future treatment in humans.
PREVAIL Treatment Trial for Men with Persistent Ebola Viral RNA
The six-month study will enroll 60 to 120 EVD survivors.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Investigational Malaria Vaccine Protects Healthy U.S. Adults
Researchers at NIH have found that the malaria vaccine protected a small number of healthy, malaria-naïve adults in the U.S. from infection for more than one year after immunization.
AACR 2016: Cancer Immunotherapy and Beyond
At this year's meeting there was a palpable buzz around subjects ranging from microbiomics to the tumor microenvironment and cancer vaccines, big data to in vitro and in vivo modeling and drug delivery (to name just a few).
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
Study Finds Factors That May Influence Influenza Vaccine Effectiveness
Researchers at NIH have suggested that the long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited.
BMS’s Opdivo Clinical Trial Shows Promise
Safety profile of the combination regimen from CheckMate -069 was consistent with previously reported studies and adverse events were managed using established safety algorithms.
Treatment of Common Prostate Cancer
Researchers at UTSW have found that the prostate cancer treatments suppress immune response and may promote relapse.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!